Oct 18 Suven Life Sciences Ltd
* Secures two product patents in europe and israel
* Patents corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases
* Patents are valid through 2030 and 2029 Source text: bit.ly/2dnOtFo Further company coverage: (Bengaluru newsroom)
Aixtron, Fujian to explore what is left of deal after U.S. veto
FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.